Background There is no proven specific pharmacological treatment for patients with the
acute respiratory distress syndrome (ARDS). The efficacy of corticosteroids in ARDS …

We read with interest the article by Garrigues et al. 1 where they described persistent
symptoms and altered quality of life 100 days after hospitalization for Coronavirus disease …

Oxygen therapy is currently used as a supportive treatment in septic patients to improve
tissue oxygenation. However, oxygen can exert deleterious effects on the inflammatory …

Abstract Coronavirus Disease-19 (COVID-19) symptoms range from mild to severe illness;
the cause for this differential response to infection remains unknown. Unravelling the …

INTRODUCTION AND OBJECTIVES: Levosimendan is an inotropic agent that is effective in
the treatment of heart failure. However, experience with levosimendan in patients with …

First, second and third wave of COVID-19. What have we changed in the ICU management of
these patients? - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

IMPLICATIONS: Comparing three different approaches to the sciatic nerve with 0.75%
ropivacaine, the classic and subgluteal approaches exhibited a faster onset time of sensory …

BACKGROUND: Various factors markedly affect the onset time and success rate, of
peripheral nerve blockade. This prospective, randomized, double-blind study, compared a …

Aims Dexmedetomidine is a selective agonist of α 2-adrenergic receptors with clinical
anesthetic and analgesic properties that has also shown neuroprotective effects on several …

Background Sevoflurane is an anesthetic agent which also participates in protective
mechanisms in sepsis, likely due to anti-inflammatory properties. A key tissue in sepsis is the …